Pacific Biosciences of California, Inc. (PACB) Investor Relations Documents

Pacific Biosciences of California, Inc. (PACB) investor relations documents from the company's IR site: 40 press releases. Read in-app with summaries. First-party data.

Investor relations documents — source: company IR site
PublishedTypeDocument
2026-08-05Press releasePress release
2026-08-05Press releasePress release
2026-08-05Press releasePress release
2026-08-05Press releasePacBio Appoints Mark Van Oene as President and Chief Executive Officer
2026-08-05Press releasePacBio Announces Second Quarter 2026 Financial Results
2026-08-05Press releasePacBio Announces Faster Runs, Up to 50% More HiFi Data, and New Compliance Controls for the Vega system
2026-07-28Press releasePress release
2026-07-28Press releasePacBio to Participate in the Canaccord Genuity 46th Annual Growth Conference
2026-07-20Press releasePress release
2026-07-15Press releasePress release
2026-07-15Press releasePacBio to Report Second Quarter 2026 Financial Results on August 5, 2026
2026-06-06Press releasePress release
2026-05-26Press releasePress release
2026-05-26Press releasePacBio SPRQ-Nx Chemistry Now Shipping Worldwide, Enabling Sub-$300 HiFi Genomes for Large Scale Projects and AI-Enhanced
2026-05-21Press releasePress release
2026-05-21Press releasePacBio to Participate in the Jefferies Global Healthcare Conference
2026-05-11Press releasePress release
2026-05-11Press releaseHiFi Solves Sub-fertility Consortium in Asia Pacific Reports First Major Study Using HiFi Long-Read Sequencing to Invest
2026-05-07Press releasePacBio Announces First Quarter 2026 Financial Results
2026-05-07Press releasePress release
2026-05-07Press releasePacBio to Report First Quarter 2026 Financial Results on May 7, 2026
2026-04-21Press releasePress release
2026-04-21Press releasePacBio and Lucid Genomics Announce Compatibility Collaboration to Advance Tertiary Analysis for Long-Read Sequencing
2026-04-16Press releasePress release
2026-04-15Press releasePress release
2026-04-15Press releasePacBio and Covaris Announce Joint Workflow Enabling HiFi Long-Read Sequencing of FFPE Tumor Samples
2026-03-18Press releasePress release
2026-03-18Press releaseBasecamp Research Selects PacBio HiFi Sequencing to Power Trillion Gene Atlas Initiative
2026-03-05Press releasePress release
2026-03-05Press releasePacBio Announces the Appointment of Chris Gibson to the Board of Directors
2026-02-24Press releasePress release
2026-02-24Press releasePacBio and DNAstack Launch First Global Federated HiFi Whole Genome Dataset to Accelerate Rare Disease Research
2026-02-18Press releasePress release
2026-02-18Press releasePacBio to Participate in the TD Cowen 46th Annual Health Care Conference
2026-02-12Press releasePress release
2026-02-12Press releasePress release
2026-02-12Press releasePacBio Joins iHope Initiative as First Long-Read Genomic Sequencing Partner
2026-02-02Press releasePress release
2026-02-02Press releasePacBio Completes Sale of Short-Read Sequencing Assets
2026-01-27Press releasePacBio to Report Fourth Quarter and Full Year 2025 Financial Results on February 12, 2026

PACB overview · PACB earnings · PACB financials · PACB KPIs · PACB ownership · PACB peers · PACB filings

Documents published by the company on its investor-relations site; summaries are model-written. Not personalized investment advice.